The country's top antitrust regulator Korea Fair Trade Commission (KFTC) could probe Samsung Life Insurance for violating shareholder regulations in allegedly providing improper benefits to another affiliate.
It is currently facing punitive measures by financial authorities on the same allegation.
The KFTC said it received filings by a local civic group Solidarity for Economic Reform last week and is considering whether to open a probe into Samsung Life Insurance for allegedly providing improper benefits to another affiliate.
It is alleged that Samsung's life insurance unit exempted the IT service provider Samsung SDS from paying indemnities for failing to complete a 156 billion won project on time.
In a 156.1 billion won contract that Samsung Life signed with Samsung SDS in 2015, the latter is required to set up an enterprise resource planning (ERP) system to manage business processes by April 2017.
The project was not completed until October 2017.
Samsung Life subsequently failed to file 15 billion won in indemnities against Samsung SDS for the delay.
Financial authorities determined that Samsung's life insurance affiliate, which owns stakes in Samsung SDS, decided to sustain losses for the latter’s benefit.
This is seen as a possible violation of regulations that limit transactions by major shareholders.
In December 2020, the FSS decided to sanction Samsung Life for the move, in addition to other issues concerning insurance payments.


Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
California Drops Lawsuit Over Federal Funding Cuts to High-Speed Rail Project
Najib Razak Awaits Court Rulings in 1MDB Case as Malaysia’s Anti-Graft Drive Faces Test
European Defense Stocks Slide as Trump Signals Progress in Ukraine-Russia Peace Talks
Italy Supreme Court Upholds Salvini Acquittal in Migrant Kidnapping Case
South Korea Factory Output Misses Forecasts in November Amid Ongoing Economic Uncertainty
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Bolsonaro Undergoes Second Medical Procedure for Persistent Hiccups While Hospitalized in Brasilia
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
Federal Reserve Begins Treasury Bill Purchases to Stabilize Reserves and Money Markets 



